CH_Expat
Posted - 22 hours ago
$DAWN $IDYA $ARVN
Current Top-3 of my undervalued underperformers in Bioland. Missed the XBI-Run from 60 to 100 completely. Huge potential for doubles here.
Adamseb14
Posted - 22 hours ago
$VTGN collecting 100,000 shares by next year, and is nice to be able to buy them cheaply, great opportunity . $VRCA $ARVN $CRMD is you considering a fine stock this is your chance
Goingforthe10bagger
Posted - 1 day ago
$ARVN I’m up 3,282 shares with an average right around $23. I want to buy some July Call Options as well.
BlackFlag1984
Posted - 1 day ago
$ARVN in at 21.90 waited and got lucky. Only up from here.
briefingcom
Posted - 1 day ago
$ARVN: Arvinas and Pfizer ($PFE) provide ongoing VERITAC-2 Phase 3 second-line clinical trial update; top-line data anticipated in the first quarter of 2025 https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241119061856ARVN&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
RonIsWrong
Posted - 2 days ago
$ARVN Pfizer, Arvinas delay late-stage trial for breast cancer therapy Arvinas (NASDAQ:ARVN) announced that the company and its partner, Pfizer (NYSE:PFE), decided to postpone the projected completion date for their jointly conducted Phase 3 trial for the breast cancer therapy vepdegestrant. Accordingly, the VERITAC-2 monotherapy clinical trial, designed to test the protein degrader in patients with metastatic breast cancer, is expected to be completed in January, a delayed timeline from the companies’ previous projection for November 2024. The duo has made the decision based on the current trial status, including data on enrollments and blinded event rates. Given the revised completion date, Pfizer (NYSE:PFE) and Arvinas (NASDAQ:ARVN) expect to share topline data from VERITAC-2 in Q1 2025. With its Q3 2024 results, New Haven, Connecticut-based Arvinas (ARVN) said VERITAC-2, which has completed enrollments in Q4, is anticipated to generate topline data this year or Q1 2025.
Goingforthe10bagger
Posted - 3 days ago
$ARVN what is the next 6-9 month outlook for this stock? Seems to have great price forecast?
CH_Expat
Posted - 5 days ago
$ARVN EV here 500m. Got it.
CH_Expat
Posted - 5 days ago
$ARVN Back in with 950 shares for 23.85 USD.
GJ_Rockabilt
Posted - 1 week ago
@Adamseb14 That might bode well for NRXP, especially if they FORWARD SPLIT Hope Therapeutics, but how do you feel about that? BTW, what does that have to do with $ARVN?
KingNeptune
Posted - 1 week ago
@MoeMoneyWiseGuy whoa! Was that really the Department of Health head? Ugh. Yes to $IBRX though. Grab some $ADXN and $ARVN with it. Bought these all around the same time. Ready for the pop.
Adamseb14
Posted - 2 weeks ago
$VTGN Post-election, the government may prioritize mental health policies due to increasing awareness around mental health issues. This can translate into expanded funding for mental health research and faster approval processes for innovative therapies, like those VistaGen is developing. Increased government support would create a favorable backdrop for $VTGN’s growth. $VRCA $CRMD $ARVN
GJ_Rockabilt
Posted - 2 weeks ago
As a reminder to $ARVN Investors, according to Google, Verzenio + hormone therapy showed a 35% reduction in the risk of cancer returning compared with hormone therapy alone. In a study, 85.5% of people taking Verzenio + hormone therapy were alive without their cancer returning vs 78.6% taking hormone therapy alone.
NoRisksNoFun
Posted - 2 weeks ago
$NMRA is it a bag? $ARVN $MDGL $VKTX $ARDX ???
NoRisksNoFun
Posted - 10/30/24
$ARVN %70 revenue surprise $VKTX $ibrx $NMRA $VYGR
OpenOutcrier
Posted - 10/30/24
$ARVN (+7.3% pre) Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update https://ooc.bz/l/46193
AivelX
Posted - 10/29/24
💡 #AivelX Premarket Earnings Insights (1/5) 🧵 Earnings breakdown for: ABBV, ADP, ARVN, BG $ABBV - Ref.Earnings: 755 Gap Up Prob.: 48%, max 8.4%, min -22.4%, avg -0.7% Avg Low vs Open: -3.2% Avg Close vs Low: 1.6% Avg Low-High %: 5% 5 Days Later: 65% new highs, 59% new lows Earnings Day: 24% broke 175 (-7.6%) $ADP - Ref.Earnings: 2530 Gap Up Prob.: 68%, max 21.9%, min -14.5%, avg 0.9% Avg Low vs Open: -1.2% Avg Close vs Low: 2.5% Avg Low-High %: 3.8% 5 Days Later: 76% new highs, 45% new lows Earnings Day: 4% broke 279.2 (-3.3%) $ARVN - Ref.Earnings: 15 Gap Up Prob.: 80%, max 18.1%, min -4.8%, avg 3% Avg Low vs Open: -1.7% Avg Close vs Low: 3.3% Avg Low-High %: 5% 5 Days Later: 67% new highs, 47% new lows Earnings Day: 87% broke 29 (+6%) $BG - Ref.Earnings: 20 Gap Up Prob.: 60%, max 7.1%, min -6.4%, avg 0% Avg Low vs Open: -2.8% Avg Close vs Low: 2.1% Avg Low-High %: 5.5% 5 Days Later: 75% new highs, 45% new lows Earnings Day: 55% broke 90.8 (+2.4%)
NoRisksNoFun
Posted - 10/29/24
$tgtx $ARVN $NVAX $EBS $AUPH
KingNeptune
Posted - 10/28/24
$FDMT starting to gain some momentum again. Need $ADXN and $ARVN to start gaining to. Let's go!
NoRisksNoFun
Posted - 10/28/24
$ibrx $sava $tgtx $auph $ARVN
CH_Expat
Posted - 10/28/24
$ARVN Action here is not normal at all. Fishy.
NoRisksNoFun
Posted - 10/28/24
$SNTI all in! $NMRA $ibrx $ARVN
Estimize
Posted - 10/28/24
Estimize EPS expectations are 49.51% lower than that of Wall Street for $ARVN Q3 [Reporting 10/30 BMO]
http://www.estimize.com/intro/arvn?c
CH_Expat
Posted - 10/25/24
$ARVN Weird price action. On the bench and ready to enter the pitch in the 24s.
SwingTradesClub
Posted - 10/25/24
$ARVN someone is On board here for next week
NoRisksNoFun
Posted - 10/24/24
$ARVN $IBRX $NMRA $VKTX whales are on board!
NoRisksNoFun
Posted - 10/24/24
$ARVN $NMRA -positioned best ofall for potential take over $IBRX $VKTX
KingNeptune
Posted - 10/24/24
@Scheissefinger hope lots of them. Digging $IBRX right now. Think I bought them the same time as $ADXN $MLTX $ARVN. Haven't been the home runs I expected yet, but all have it in them with time and PR. Slow and steady.
Adamseb14
Posted - 10/24/24
$VTGN That pales in comparison to the S&P 500. The index posted positive annualized returns of 41% for one year, 10% for three years, and 16% for five years. $VRCA $ARVN $CRMD
